Latest court orders, judgments, and legal developments from Indian courts — AI-curated and summarized.
Zee Entertainment files a lawsuit against Nykaa, claiming INR 2 crores for unauthorized use of copyrighted music in Instagram reels.
The Delhi High Court has officially declared GSK's CALPOL as a well-known trademark amid a trademark infringement suit. This recognition acknowledges the brand's reputation and protects it from unauthorized use.
The Delhi High Court's recent pro-tem order in the Malikie v. Xiaomi case signifies ongoing challenges in determining fair, reasonable, and non-discriminatory (FRAND) terms for standard essential patents (SEPs).
The Calcutta High Court has upheld the economic rights of authors over their works in a recent ruling, emphasizing the intent behind the copyright amendments of 2012.
The Delhi High Court addressed the complexities surrounding Section 3(k) of the Indian Patents Act in the case Blackberry v. Controller. Despite previous guidelines, the interpretation of patentability remains unclear.
The Calcutta High Court has reaffirmed the continuing rights of authors under the copyright amendments of 2012. The ruling clarifies the rights of authors in relation to sound recordings, reinforcing their economic entitlements.
Zee Entertainment has filed a lawsuit against Nykaa, seeking damages of INR 2 crores for the alleged unauthorized use of copyrighted songs in Instagram reels. This case highlights the ongoing struggles related to copyright enforcement in the digital marketing space.
The Delhi High Court, in Blackberry v. Controller, reiterated the ambiguous nature of Section 3(k) of the Indian Patents Act. The court emphasized the ongoing confusion surrounding the patentability of specific inventions under this provision despite the recent CRI Guidelines.
The Calcutta High Court has reinforced the rights of authors concerning sound recordings, emphasizing the necessity for economic benefits from copyright provisions for underlying works.
Recent developments involving the Serum Institute of India regarding a Nipah vaccine and the sidelining of an indigenous HPV vaccine highlight ongoing issues in India's vaccine policy. These cases underscore significant challenges related to transparency and access.
The Delhi High Court's recent pro-tem order in Malikie v. Xiaomi raises concerns for SEP jurisprudence in India. The order highlights confusion in essentiality assessment and rate calculation.
In Huntington Alloys v Union of India, the Bombay HC scrutinizes the lack of rationale in the IPO's refusal of an atomic energy patent, raising important issues on patent adjudication.